This announcement is a separate document:
康諾亞-B:自願性公告CMG901 (AZD0901) I期臨床研究數據最新結果在ASCO Annual Meeting 2024以口頭報告形式公佈
KEYMED BIO-B: VOLUNTARY ANNOUNCEMENTTHE LATEST RESULTS FROM A PHASE I CLINICAL STUDY OFCMG901 (AZD0901) AT THE ASCO ANNUAL MEETING 2024 BY WAY OFORAL PRESENTATION
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.